Navigation Links
Corning Spin-X Centrifuge Tube Filters from Sigma-Aldrich

ProductsCorning Spin-X Centrifuge Tube Filters from Sigma-Aldrich
Company Sigma-Aldrich
Item Corning Spin-X Centrifuge Tube Filters
Price 
Description Use in any standard fixed-angle microcentrifuge rotor at RCF up to 16,000 g. Spin- centrifuge tube filters consist of a membrane-containing filter unit within a centrifuge tube. They filter by centrifugation for bacteria removal, particle removal, HPLC sample preparation, removal of cells from media and DNA removal from agarose or acrylamide gels.
Info Sigma-AldrichSigma-Aldrich
Sigma-Aldrich Corp.
St. Louis, MO, USA
Customer Service: 800-325-3010
Tech Support: 800-325-5832
Fax Number: 314-771-5757
Web Site: http://www.sigmaaldrich.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Corning Proculture Spinner Flask,15L,Vertical S/Arm, No. Of S/A 4,Cent Neck 100mm from Sigma-Aldrich
2. Corning Gaps Ii Bar-Coded Coated Slides from Sigma-Aldrich
3. Corning Petri Dish, 60 X 15 mm, Tc -Treated, Sterile from Sigma-Aldrich
4. Corning Roller Bottle Easy Grip Caps, Sterile from Sigma-Aldrich
5. Corning Cryo Vial Rack, PC, Holds 30 Self-Standing Vials, Non-Sterile from Sigma-Aldrich
6. Corning Resuable Pp Vial Rack, Non-Sterile, 50 Positions, Self Locking Design from Sigma-Aldrich
7. Corning Cryo Vial Rack & Tray, PC,Holds 30 Self-Standing Vial In Bath,Non-Sterile from Sigma-Aldrich
8. Corning Cryo Box, 81 Position, 4-5 ml, Non-Sterile from Sigma-Aldrich
9. Corning Cryo Box For Internal Thread Vials Only,100 Position,1-2 ml,Non-Sterile from Sigma-Aldrich
10. 801 Rotor System with 305/315, 6 50 ml Falcon/Corning from Thermo Scientific
11. 809 Rotor System with 302/668, 12 15 ml Falcon/Corning from Thermo Scientific
Hybridization Buffer from BD Biosciences Pharmingen
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
Proteinase K Buffer from BD Biosciences Pharmingen
Rabbit Anti-VEGF Receptor 2, phospho (Tyr1214) Polyclonal Antibody, Unconjugated from Abcam
Biology Products:
(Date:12/2/2009)..., , REDWOOD CITY, Calif., Dec. 2 /PRNews...rint identity and authentication solutions, today ...del of its DigitalPersona biometric fingerprint te...gitalPersona U.are.U® 4500HD offering allows ...kly identify users so that specific transactions c...
(Date:12/2/2009)..., , Before one of your muscles can twitch, before... nerve, a tiny floodgate of sortscalled an ion cha... organs to let in the chemical signals that spur t...nstitute of Standards and Technology (NIST) has al...e surface membrane for the first time, potentially...
(Date:12/2/2009)..., New York, NY, December 2, 2009 Commonly prescr...ment of asthma in pregnant women as well as pre-te...trum disorders, psychiatric pathology, cognitive p...ren, according to a new study published in the Dec...trics & Gynecology . , Beta 2 adrenergic agonist...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Nervy research: Researchers take initial look at ion channels in a model system 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2IH Systems RIVA Top Pick for Directors of Pharmacy 57370 1IH Systems RIVA Top Pick for Directors of Pharmacy 57370 2HMS Awarded Third Party Liability Services Contract by Minnesota 57366 1Dr Drew and Drug Czar Host Online Chat 57362 1
...009) The Michael & Susan Dell Center for Advancem...chool of Public Health Austin Regional Campus will...eship in Child Health at 1:30 p.m. Thursday, April...e Center Amphitheater in Austin. , Obesity expe...biostatistics and epidemiology at the University o...
...astatic prostate cancer has shown considerable pro...hose disease has become resistant to current drugs...gues at several other institutions, including Memo... new drug to treat a particularly lethal form of t... cancer, or CRPC. Also referred to as hormone-refr...
...9, 2009 -- Four experts in soil carbon research, f...tunity farmers and foresters have to manage soil c...ate in voluntary markets. Agricultural and forest ...50 million metric tons of carbon dioxide (CO 2 ) e... gas emissions. , The briefing, "Down to Earth Ca...
Other Biology News:Annual Michael & Susan Dell lectureship in child health 2New drug shows promise in treating drug-resistant prostate cancer 2New drug shows promise in treating drug-resistant prostate cancer 3New drug shows promise in treating drug-resistant prostate cancer 4Down to Earth carbon science: Briefing April 15 in DC 2
(Date:12/2/2009)...SINGAPORE, Dec. 2 S*BIO Pte Ltd to... JAK2 inhibitor, SB1518, at The American Society o... New Orleans. ,, Data will be presented on the ...trial of SB1518 detailing its safety, tolerability...le in dose levels ranging from 100 to 600 mg. Thes...
(Date:12/2/2009)... SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world i...n turmoil and uncertainty is part of many,business...dustry has been,relatively immune to the economic ... , During the midst of the difficult time...; Johnson inaugurated an R&D center in Shangha...
(Date:12/1/2009)... VILLAGE, Nev., Dec. 1 P...nounced revenue guidance for the fourth quarter en..., as compared with $69 million for the fourth quar...ts was the first of two installment payments of $1... quarter 2008 results was a one-time $1.8 million ...
(Date:12/1/2009)...TH, Mass., Dec. 1 Harvest Technolo... results from the company sponsored 60-patient cli...enter in Chennai, India using the company,s BMAC S...ritical Limb Ischemia (CLI). Sri Ramachandra Medic...iated institution based in Chennai, India and one ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3